| Health / Medical Topics |
MAGE-3.A1 Peptide Vaccine
A synthetic peptide cancer vaccine consisting of human leukocyte antigen HLA-A1-restricted peptide derived from human melanoma antigen 3 (MAGE-3) with potential immunostimulating and antineoplastic activities. Upon administration, MAGE-3.A1 peptide vaccine may stimulate the immune system to mount a cytotoxic T-cell (CTL) response against tumor cells expressing MAGE-3, resulting in tumor cell lysis. MAGE-3, a tumor-associated antigen (TAA), is overexpressed by a variety of cancer cell types. (NCI Thesaurus)
YOU MAY ALSO LIKE
A cancer vaccine consisting of a peptide derived from MAGE-3 and the pan-DR epitope (PADRE), an immunostimulant. Vaccination with CY-2010 may…
A peptide derived from MAGE-3, a tumor-associated protein expressed by a variety of cancer cell types, including melanoma, breast, colon, lung, and…
A protein found in many types of tumors but not in most normal tissues. Vaccines using pieces of the MAGE-3 protein are…
A synthetic peptide consisting of the amino acids 170 through 178 of the MAGE-12 melanoma antigen. MAGE-12 170-178 has been identified…
A synthetic vaccine comprised of a peptide consisting of peptide fragments of melanoma-associated antigen 12 (MAGE-12). MAGE-12 has been identified as an…
A synthetic nonapeptide derived from a melanoma-associated antigen. Vaccination with MAGE-10.A2 may stimulate a host cytotoxic T-cell response against tumor cells that…
